Select Medical Holdings
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Select Medical Holdings generated cash of $582,058,000, which is more than the previous year. Cash used in financing activities reached the amount of -$327,481,000 last year. Net change in cash is therefore -$13,900,000.
Cash Flow
| 2014 | 170.64M | -101.09M | -70.51M |
|---|---|---|---|
| 2015 | 208.41M | -1.21B | 1.01B |
| 2016 | 346.60M | -554.32M | 292.31M |
| 2017 | 238.13M | -192.96M | -21.64M |
| 2018 | 494.19M | -697.13M | 255.57M |
| 2019 | 445.18M | -316.72M | 32.25M |
| 2020 | 1.02B | -115.35M | -671.54M |
| 2021 | 401.22M | -256.59M | -647.38M |
| 2022 | 284.82M | -226.33M | -34.89M |
| 2023 | 582.05M | -268.47M | -327.48M |
SEM Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 97.90M | 74.31M | 577.06M | 335.88M | 175.17M | 122.54M | 99.02M | 14.43M | 3.35M | 4.31M |
Operating activities | ||||||||||
Net income | 299.73M | 198.02M | 499.94M | 344.60M | 201.03M | 176.94M | 220.64M | 125.27M | 135.99M | 128.17M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 208.74M | 205.82M | 202.64M | 205.65M | 212.57M | 201.65M | 160.01M | 145.31M | 104.98M | 68.35M |
Stock-based compensation expense | 43.80M | 37.75M | 30.94M | 27.25M | 26.45M | 0 | 19.28M | 17.41M | 14.98M | 11.18M |
| Deferred income tax benefit | 43.80M | 37.75M | 30.94M | 27.25M | 26.45M | 0 | 19.28M | 17.41M | 14.98M | 11.18M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 1.15M | -52.18M | 23.10M | -116.60M | -57.99M | 54.57M | -197.19M | -39.32M | -92.57M | -97.80M |
Inventories | 0 | 0 | -82.77M | 167.65M | 33.03M | 0 | 1.59M | 17.45M | 4.69M | -17.76M |
Accounts payable | -6.41M | -48.04M | 53.39M | 27.32M | 5.74M | 26.11M | 21.24M | 30.8M | 2.34M | 5.99M |
Cash generated by operating activities | 582.05M | 284.82M | 401.22M | 1.02B | 445.18M | 494.19M | 238.13M | 346.60M | 208.41M | 170.64M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1M | -3.44M | 0 |
Investments In Property Plant And Equipment | -229.2M | -190.37M | -180.53M | -146.44M | -157.12M | -167.28M | -233.24M | -161.63M | -182.64M | -95.24M |
Acquisitions Net | -39.44M | -44.31M | -102.87M | -52.23M | -159.79M | -536.61M | -40.07M | -473.15M | -1.03B | -5.84M |
Cash generated by investing activities | -268.47M | -226.33M | -256.59M | -115.35M | -316.72M | -697.13M | -192.96M | -554.32M | -1.21B | -101.09M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 235.36M | 0 | 0 | 1.72M | 0 | 1.67M | 1.64M | 7.35M |
Payments for dividends | -63.90M | -64.58M | -50.6M | 0 | 0 | 0 | 0 | 0 | -13.12M | -53.36M |
Repurchases of common stock | -12.75M | -195.52M | -79.47M | -16.03M | -38.53M | -6.83M | -4.75M | -2.92M | -15.82M | -130.73M |
Repayments of term debt | -203.95M | 264.68M | -39.66M | -558.22M | 73.46M | -846.12M | -18.27M | -1.11B | 836.54M | -918.66M |
Cash used in financing activities | -327.48M | -34.89M | -647.38M | -671.54M | 32.25M | 255.57M | -21.64M | 292.31M | 1.01B | -70.51M |
Net Change In Cash | -13.9M | 23.59M | -502.75M | 241.17M | 160.70M | 52.62M | 23.52M | 84.59M | 11.08M | -965K |
Cash at end of period | 84.00M | 97.90M | 74.31M | 577.06M | 335.88M | 175.17M | 122.54M | 99.02M | 14.43M | 3.35M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |